AstraZeneca (AZN +0.25%) completes its $1.26B acquisition of Ardea Biosciences (RDEA), which...

|About: AstraZeneca Group plc (AZN)|By:, SA News Editor

AstraZeneca (AZN +0.25%) completes its $1.26B acquisition of Ardea Biosciences (RDEA), which develops two potential drugs for gout and one for cancer.